NPI: 1134194038 · WILMINGTON, DE 19801 · General Acute Care Hospital · NPI assigned 02/22/2006
Authorized official MCMURRAY, ROBERT controls 20+ related entities in our dataset. Read more
| Authorized Official | MCMURRAY, ROBERT (CFO) |
| NPI Enumeration Date | 02/22/2006 |
Other providers sharing the same authorized official: MCMURRAY, ROBERT
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 759,725 | $5.71M |
| 2019 | 623,069 | $17.14M |
| 2020 | 405,998 | $31.56M |
| 2021 | 207,871 | $11.06M |
| 2022 | 324,616 | $13.72M |
| 2023 | 353,729 | $12.83M |
| 2024 | 191,189 | $7.18M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 183,443 | 127,879 | $17.53M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 100,839 | 70,587 | $8.09M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 63,078 | 46,103 | $6.44M |
| 41899 | Unlisted procedure, dentoalveolar structures | 2,744 | 2,131 | $5.75M |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 33,940 | 25,444 | $3.32M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 42,154 | 31,096 | $3.31M |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 583 | 385 | $2.75M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 5,974 | 4,646 | $2.71M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 32,858 | 7,963 | $2.39M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 21,460 | 13,280 | $2.15M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 14,623 | 11,615 | $1.53M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 235,265 | 150,451 | $1.41M |
| J2505 | Injection, pegfilgrastim, 6 mg | 341 | 198 | $1.30M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 19,689 | 5,823 | $1.26M |
| 80048 | Basic metabolic panel (calcium, ionized) | 82,530 | 52,221 | $1.08M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 77,250 | 53,693 | $1.04M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 25,543 | 18,291 | $984K |
| 93971 | 4,215 | 3,447 | $895K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 20,528 | 5,178 | $893K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 28,251 | 20,547 | $841K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 28,252 | 20,549 | $837K |
| G0378 | Hospital observation service, per hour | 8,488 | 4,089 | $773K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 21,231 | 14,528 | $725K |
| 80053 | Comprehensive metabolic panel | 53,925 | 36,078 | $700K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 8,386 | 6,701 | $689K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 17,602 | 12,365 | $688K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 758 | 386 | $682K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 42,673 | 30,717 | $675K |
| 70450 | Computed tomography, head or brain; without contrast material | 16,507 | 12,848 | $665K |
| 93970 | 2,124 | 1,785 | $637K | |
| 80051 | 61,281 | 43,945 | $603K | |
| 71046 | Radiologic examination, chest; 2 views | 54,610 | 39,600 | $537K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 6,930 | 2,039 | $527K |
| 87536 | 8,607 | 6,131 | $491K | |
| 97161 | 5,289 | 4,175 | $467K | |
| 77386 | 740 | 53 | $458K | |
| 84484 | 38,218 | 25,795 | $444K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 13,729 | 9,536 | $438K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 15,572 | 9,410 | $430K |
| 87631 | 4,306 | 3,552 | $414K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 5,855 | 4,632 | $398K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3,585 | 2,080 | $393K |
| 76801 | 7,075 | 4,738 | $372K | |
| 76830 | Ultrasound, transvaginal | 7,746 | 6,218 | $348K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 8,221 | 6,611 | $348K |
| 96367 | 3,028 | 1,406 | $313K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 4,887 | 3,923 | $312K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 8,567 | 6,268 | $312K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 3,355 | 2,600 | $306K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 519 | 425 | $293K |
| 72125 | Computed tomography, cervical spine; without contrast material | 5,717 | 4,551 | $291K |
| J2704 | Injection, propofol, 10 mg | 21,333 | 12,412 | $289K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 2,278 | 1,963 | $276K |
| 93458 | 268 | 70 | $259K | |
| 80061 | Lipid panel | 23,753 | 17,122 | $253K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 6,186 | 3,871 | $249K |
| 80076 | 18,222 | 13,361 | $240K | |
| 36430 | 1,664 | 1,027 | $239K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 6,906 | 3,802 | $238K |
| 90715 | 4,215 | 3,533 | $238K | |
| 77412 | 1,863 | 192 | $235K | |
| J1453 | Injection, fosaprepitant, 1 mg | 719 | 402 | $233K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 258 | 238 | $226K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 28,525 | 19,595 | $222K |
| 82565 | 70,178 | 50,169 | $214K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 3,447 | 1,189 | $202K |
| 84443 | Thyroid stimulating hormone (TSH) | 23,315 | 17,429 | $190K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 27,860 | 20,924 | $190K |
| 83690 | 26,144 | 18,992 | $190K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 29,263 | 17,891 | $187K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 23,449 | 17,530 | $172K |
| J0897 | Injection, denosumab, 1 mg | 203 | 170 | $166K |
| 84520 | 63,142 | 45,349 | $166K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 2,255 | 1,761 | $165K |
| 82947 | 64,500 | 46,098 | $162K | |
| 77066 | Tomosynthesis, mammo | 1,731 | 1,366 | $160K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 578 | 468 | $159K |
| 95886 | 1,019 | 812 | $156K | |
| 83605 | 13,276 | 9,636 | $152K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 4,202 | 3,280 | $151K |
| 83735 | 22,183 | 13,190 | $147K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 3,808 | 3,153 | $147K |
| 71250 | 3,500 | 2,946 | $146K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 8,704 | 5,698 | $145K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1,041 | 733 | $134K |
| 87660 | 10,471 | 8,162 | $134K | |
| 87480 | 10,461 | 8,160 | $134K | |
| 87510 | 10,445 | 8,145 | $133K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 8,225 | 6,564 | $133K |
| 97535 | Self-care/home management training, each 15 minutes | 3,202 | 1,107 | $132K |
| 82728 | 11,921 | 8,605 | $131K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 17,112 | 10,237 | $128K |
| 97116 | 4,336 | 1,542 | $123K | |
| 86803 | 9,281 | 6,430 | $119K | |
| 47562 | 207 | 154 | $118K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 1,016 | 730 | $118K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1,510 | 1,254 | $117K |
| 93880 | 731 | 612 | $114K | |
| 70498 | 1,160 | 873 | $113K | |
| 84703 | 12,957 | 9,628 | $112K | |
| 93798 | 2,219 | 410 | $111K | |
| 88307 | 1,603 | 1,172 | $109K | |
| J2785 | Injection, regadenoson, 0.1 mg | 993 | 601 | $108K |
| 97165 | 1,488 | 1,187 | $108K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 8,287 | 4,825 | $105K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 4,137 | 3,124 | $105K |
| J1650 | Injection, enoxaparin sodium, 10 mg | 10,051 | 3,840 | $103K |
| 93000 | 4,946 | 3,577 | $102K | |
| 94726 | 1,305 | 1,138 | $102K | |
| 81001 | 34,371 | 25,322 | $102K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 1,036 | 623 | $100K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 7,414 | 5,534 | $100K |
| 70491 | 1,390 | 1,150 | $96K | |
| 93308 | 328 | 302 | $94K | |
| 92526 | 1,530 | 693 | $91K | |
| 77065 | Tomosynthesis, mammo | 1,233 | 1,019 | $89K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,340 | 1,003 | $89K |
| 76642 | 3,301 | 2,379 | $88K | |
| 11981 | 309 | 241 | $88K | |
| 93922 | 642 | 551 | $86K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 388 | 212 | $86K |
| 83036 | Hemoglobin; glycosylated (A1C) | 18,418 | 13,720 | $86K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 392 | 213 | $85K |
| 84702 | 7,170 | 4,182 | $84K | |
| 86360 | 3,981 | 2,818 | $83K | |
| 87077 | 8,490 | 6,523 | $83K | |
| 97162 | 1,032 | 871 | $82K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 1,020 | 706 | $80K |
| 85027 | 16,854 | 10,929 | $79K | |
| 86850 | 5,918 | 4,108 | $79K | |
| 76536 | 1,949 | 1,661 | $77K | |
| 83880 | 5,114 | 3,733 | $76K | |
| 80050 | General health panel | 3,380 | 2,668 | $76K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 18,874 | 11,745 | $74K |
| J3486 | Injection, ziprasidone mesylate, 10 mg | 1,074 | 850 | $73K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 2,915 | 2,140 | $73K |
| 87040 | 2,437 | 1,717 | $72K | |
| 73630 | 7,105 | 5,352 | $71K | |
| 86920 | 1,231 | 854 | $68K | |
| 94729 | 1,494 | 1,321 | $68K | |
| 94060 | 1,423 | 1,254 | $68K | |
| 10060 | 1,552 | 1,320 | $66K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 964 | 659 | $66K |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 5,207 | 4,269 | $65K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3,172 | 2,266 | $64K |
| C1769 | Guide wire | 3,520 | 2,310 | $63K |
| 83550 | 7,873 | 5,818 | $63K | |
| 76770 | 1,749 | 1,507 | $62K | |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 3,715 | 2,894 | $61K |
| 88341 | 1,096 | 724 | $61K | |
| 93015 | 958 | 616 | $60K | |
| 73130 | 5,111 | 3,804 | $59K | |
| 82607 | 6,155 | 4,534 | $59K | |
| 74183 | 534 | 462 | $59K | |
| 73560 | 6,141 | 4,347 | $59K | |
| 70544 | 896 | 676 | $59K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 2,697 | 2,132 | $58K |
| 86480 | 2,285 | 1,720 | $58K | |
| 77334 | 576 | 387 | $57K | |
| 72141 | 897 | 741 | $57K | |
| 87186 | 7,478 | 5,737 | $56K | |
| 88342 | 1,764 | 1,251 | $56K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 170 | 153 | $56K |
| 80055 | 1,787 | 1,102 | $56K | |
| J2310 | Injection, naloxone hydrochloride, per 1 mg | 1,255 | 966 | $55K |
| 96376 | 3,966 | 2,758 | $55K | |
| 72100 | 4,476 | 3,684 | $55K | |
| 83540 | 8,399 | 6,210 | $53K | |
| 87653 | 2,488 | 1,928 | $53K | |
| 84439 | 8,384 | 6,306 | $53K | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 5,056 | 3,472 | $49K |
| 97166 | 678 | 574 | $48K | |
| 59025 | Fetal non-stress test | 1,690 | 1,179 | $47K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 179 | 138 | $46K |
| 81003 | 21,244 | 16,035 | $46K | |
| J3370 | Injection, vancomycin hcl, 500 mg | 1,997 | 1,112 | $45K |
| 87522 | Neg quan hep c or qual rna | 2,156 | 1,652 | $44K |
| 19318 | 13 | 12 | $44K | |
| 85379 | 4,461 | 3,449 | $43K | |
| 82803 | 4,541 | 3,130 | $43K | |
| 80069 | 2,999 | 1,785 | $43K | |
| 87340 | 4,149 | 3,011 | $42K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 22,442 | 13,273 | $41K |
| 87070 | 4,118 | 3,044 | $41K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 2,746 | 2,177 | $41K |
| 70496 | 653 | 483 | $41K | |
| 87641 | 1,662 | 1,355 | $41K | |
| 82948 | 17,508 | 7,754 | $40K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1,374 | 1,163 | $40K |
| 73030 | 4,227 | 3,167 | $40K | |
| 86901 | 7,488 | 5,300 | $40K | |
| 58300 | 199 | 169 | $40K | |
| J1756 | Injection, iron sucrose, 1 mg | 600 | 203 | $39K |
| 86706 | 3,506 | 2,584 | $39K | |
| 82746 | 4,098 | 2,942 | $39K | |
| 86900 | 7,461 | 5,286 | $39K | |
| C1876 | Stent, non-coated/non-covered, with delivery system | 70 | 55 | $39K |
| 12001 | 960 | 873 | $39K | |
| 85610 | 10,800 | 6,900 | $38K | |
| 86592 | 12,804 | 8,828 | $38K | |
| 71045 | Radiologic examination, chest; single view | 7,180 | 4,797 | $37K |
| 95816 | 245 | 221 | $36K | |
| 87075 | 1,845 | 1,381 | $36K | |
| 82043 | 5,616 | 4,272 | $36K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 10,777 | 6,256 | $35K |
| 77300 | 522 | 412 | $34K | |
| 83615 | 8,110 | 5,335 | $33K | |
| 95819 | 155 | 116 | $33K | |
| 84460 | 10,312 | 8,031 | $33K | |
| 84450 | 10,071 | 7,852 | $31K | |
| 93325 | 245 | 216 | $31K | |
| 96417 | 1,483 | 789 | $31K | |
| 88312 | 1,213 | 861 | $31K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 10,502 | 6,815 | $31K |
| 73600 | 3,174 | 2,568 | $30K | |
| 85730 | 5,126 | 3,402 | $30K | |
| 70480 | 440 | 398 | $30K | |
| 77336 | 1,431 | 569 | $30K | |
| Q3014 | Telehealth originating site facility fee | 5,560 | 4,155 | $29K |
| 87088 | 7,048 | 5,420 | $29K | |
| 82784 | 1,620 | 1,224 | $28K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1,261 | 594 | $28K |
| 12011 | 709 | 641 | $28K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 2,303 | 1,519 | $28K |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 1,772 | 986 | $27K |
| 86140 | 4,957 | 3,477 | $26K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 218 | 100 | $26K |
| 58558 | 91 | 72 | $25K | |
| 92610 | 482 | 373 | $25K | |
| J1644 | Injection, heparin sodium, per 1000 units | 8,670 | 2,928 | $25K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 229 | 197 | $24K |
| 72170 | 2,798 | 2,329 | $24K | |
| 92523 | 362 | 294 | $24K | |
| 70486 | 544 | 503 | $23K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 4,519 | 3,672 | $23K |
| 74175 | 256 | 216 | $22K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 534 | 423 | $22K |
| 82247 | 7,090 | 5,434 | $22K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 3,239 | 1,853 | $22K |
| 82570 | 3,831 | 2,878 | $22K | |
| J9045 | Injection, carboplatin, 50 mg | 275 | 175 | $21K |
| 49083 | 93 | 41 | $21K | |
| 90937 | 504 | 110 | $21K | |
| 85651 | 5,811 | 4,179 | $21K | |
| 83970 | 1,045 | 895 | $20K | |
| 84075 | 6,360 | 4,982 | $20K | |
| 82731 | 471 | 373 | $20K | |
| 88304 | 1,328 | 1,053 | $20K | |
| 80074 | 833 | 544 | $20K | |
| 12002 | 523 | 455 | $19K | |
| 19083 | 134 | 109 | $19K | |
| 96415 | 1,826 | 1,129 | $19K | |
| 70547 | 336 | 224 | $19K | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 246 | 209 | $18K |
| 29125 | 598 | 524 | $18K | |
| 87205 | 3,962 | 2,812 | $18K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 643 | 506 | $18K |
| 83883 | 837 | 665 | $18K | |
| 84153 | 935 | 756 | $18K | |
| 88360 | 493 | 285 | $18K | |
| 88173 | 774 | 537 | $18K | |
| 72197 | 114 | 102 | $17K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 5,077 | 3,352 | $17K |
| A4648 | Tissue marker, implantable, any type, each | 223 | 202 | $17K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 5,065 | 3,291 | $17K |
| 82550 | 2,470 | 1,698 | $17K | |
| 82378 | 589 | 450 | $17K | |
| S5105 | Day care services, center-based; services not included in program fee, per diem | 7,552 | 324 | $16K |
| 74178 | 183 | 155 | $16K | |
| 76870 | 607 | 506 | $16K | |
| 72131 | 348 | 304 | $15K | |
| J1750 | Injection, iron dextran, 50 mg | 63 | 12 | $15K |
| 85046 | 2,750 | 1,762 | $15K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 1,940 | 1,128 | $15K |
| 83020 | 1,680 | 1,145 | $15K | |
| 73610 | 1,456 | 1,219 | $15K | |
| 82105 | 1,084 | 770 | $14K | |
| 84100 | 4,883 | 2,696 | $14K | |
| 77290 | 123 | 106 | $14K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 283 | 141 | $14K |
| 88142 | 952 | 817 | $14K | |
| OP250 | 2,029 | 1,016 | $13K | |
| 84134 | 767 | 486 | $13K | |
| 86704 | 1,410 | 1,050 | $13K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 256 | 143 | $13K |
| 84403 | 768 | 618 | $13K | |
| 73590 | 1,397 | 1,108 | $13K | |
| 74174 | 50 | 44 | $12K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 402 | 330 | $12K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,193 | 938 | $12K |
| 72158 | 96 | 81 | $12K | |
| 73140 | 1,088 | 1,000 | $12K | |
| 93224 | 15 | 15 | $12K | |
| 88313 | 539 | 355 | $11K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 587 | 373 | $11K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 101 | 80 | $11K |
| 85018 | 6,190 | 4,127 | $11K | |
| 85384 | 1,101 | 813 | $11K | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 647 | 411 | $11K |
| 73090 | 1,183 | 958 | $11K | |
| 86334 | 581 | 408 | $11K | |
| 84146 | 570 | 479 | $10K | |
| 74018 | 1,644 | 1,359 | $10K | |
| 86235 | 179 | 142 | $10K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 3,336 | 1,901 | $10K |
| 77080 | 766 | 702 | $10K | |
| 96411 | 779 | 338 | $10K | |
| 72040 | 1,075 | 907 | $10K | |
| 84156 | 3,671 | 2,746 | $10K | |
| J1953 | Injection, levetiracetam, 10 mg | 248 | 179 | $10K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 122 | 50 | $10K |
| 73110 | 815 | 721 | $10K | |
| 71271 | 131 | 75 | $10K | |
| J7297 | Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg | 14 | 14 | $9K |
| 0002A | 246 | 242 | $9K | |
| 86038 | 1,641 | 1,219 | $9K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 272 | 235 | $9K |
| 80164 | 756 | 576 | $9K | |
| 72156 | 90 | 79 | $9K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 2,833 | 2,047 | $9K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 68 | 56 | $9K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 2,441 | 1,783 | $9K |
| 52000 | 32 | 28 | $9K | |
| S9128 | Speech therapy, in the home, per diem | 118 | 38 | $9K |
| 72070 | 849 | 749 | $8K | |
| J2060 | Injection, lorazepam, 2 mg | 1,418 | 1,130 | $8K |
| 85670 | 909 | 644 | $8K | |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 23 | 22 | $8K |
| 76604 | 130 | 125 | $8K | |
| 78582 | 188 | 145 | $8K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,476 | 1,006 | $8K |
| 83001 | 466 | 361 | $8K | |
| 86708 | 697 | 556 | $8K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 4,011 | 2,175 | $8K |
| 84165 | 930 | 701 | $8K | |
| 76882 | 453 | 398 | $8K | |
| A9540 | Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries | 283 | 227 | $8K |
| 73070 | 918 | 772 | $8K | |
| 36415 | Collection of venous blood by venipuncture | 24,209 | 13,727 | $8K |
| 82670 | 149 | 142 | $7K | |
| J0640 | Injection, leucovorin calcium, per 50 mg | 139 | 63 | $7K |
| 83516 | 551 | 388 | $7K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 529 | 359 | $7K |
| 87506 | 154 | 128 | $7K | |
| 82248 | 2,264 | 1,636 | $7K | |
| 97014 | 723 | 242 | $7K | |
| J3360 | Injection, diazepam, up to 5 mg | 51 | 47 | $7K |
| C1760 | Closure device, vascular (implantable/insertable) | 163 | 98 | $7K |
| 84480 | 707 | 578 | $7K | |
| 97163 | 146 | 64 | $7K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 2,263 | 1,629 | $7K |
| 96416 | 189 | 115 | $7K | |
| 83655 | 897 | 735 | $7K | |
| 84550 | 1,788 | 1,325 | $7K | |
| 49450 | 15 | 12 | $6K | |
| 0223U | 60 | 44 | $6K | |
| J1630 | Injection, haloperidol, up to 5 mg | 2,023 | 1,528 | $6K |
| J9190 | Injection, fluorouracil, 500 mg | 272 | 118 | $6K |
| 73562 | 758 | 508 | $6K | |
| C9113 | Injection, pantoprazole sodium, per vial | 1,739 | 789 | $6K |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 250 | 163 | $6K |
| 29515 | 264 | 239 | $6K | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 238 | 138 | $6K |
| 87102 | 1,022 | 649 | $6K | |
| 94618 | 220 | 203 | $5K | |
| 86618 | 897 | 657 | $5K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 23 | 13 | $5K |
| 71101 | 556 | 502 | $5K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 19 | 17 | $5K |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 3,060 | 1,797 | $5K |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 201 | 171 | $5K |
| 93296 | 761 | 642 | $5K | |
| 88185 | 65 | 38 | $5K | |
| 90732 | 237 | 199 | $5K | |
| 86300 | 442 | 303 | $5K | |
| J1790 | Injection, droperidol, up to 5 mg | 283 | 192 | $4K |
| C1751 | Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) | 255 | 182 | $4K |
| 95910 | 12 | 12 | $4K | |
| J2323 | Injection, natalizumab, 1 mg | 121 | 108 | $4K |
| 87634 | 793 | 560 | $4K | |
| 0001A | 127 | 111 | $4K | |
| J3480 | Injection, potassium chloride, per 2 meq | 443 | 277 | $4K |
| 74021 | 541 | 443 | $4K | |
| 73700 | 45 | 40 | $4K | |
| 77280 | 39 | 28 | $4K | |
| 94664 | 608 | 407 | $4K | |
| 94010 | 44 | 44 | $4K | |
| 82150 | 473 | 360 | $4K | |
| 73552 | 605 | 441 | $3K | |
| 73060 | 381 | 331 | $3K | |
| 97750 | 13 | 12 | $3K | |
| 76937 | 651 | 477 | $3K | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 107 | 68 | $3K |
| 87902 | 122 | 88 | $3K | |
| T1027 | Family training and counseling for child development, per 15 minutes | 200 | 73 | $3K |
| 87529 | 34 | 29 | $3K | |
| 86160 | 149 | 134 | $3K | |
| 82140 | 456 | 325 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 745 | 509 | $3K |
| 87081 | 1,026 | 988 | $3K | |
| 84436 | 656 | 533 | $3K | |
| 82533 | 178 | 141 | $3K | |
| 86200 | 289 | 237 | $3K | |
| J1940 | Injection, furosemide, up to 20 mg | 959 | 484 | $3K |
| 87563 | 132 | 80 | $2K | |
| 90686 | 833 | 683 | $2K | |
| 86787 | 344 | 224 | $2K | |
| 77295 | 25 | 15 | $2K | |
| J2791 | Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu | 49 | 39 | $2K |
| 83002 | 158 | 135 | $2K | |
| 74181 | 33 | 29 | $2K | |
| 87254 | 273 | 149 | $2K | |
| 86430 | 910 | 740 | $2K | |
| 96523 | 94 | 81 | $2K | |
| 97113 | 99 | 25 | $2K | |
| 96368 | 158 | 90 | $2K | |
| 78306 | 27 | 25 | $2K | |
| 82330 | 318 | 239 | $2K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 15 | 12 | $2K |
| 97542 | 15 | 12 | $2K | |
| 87015 | 587 | 249 | $2K | |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 231 | 172 | $2K |
| 97602 | 21 | 13 | $2K | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 134 | 107 | $2K |
| 82977 | 582 | 442 | $2K | |
| 73100 | 232 | 190 | $2K | |
| 85347 | 82 | 70 | $2K | |
| 88112 | 208 | 101 | $2K | |
| 0012A | 46 | 45 | $2K | |
| G0008 | Administration of influenza virus vaccine | 1,939 | 1,602 | $2K |
| 94660 | 594 | 324 | $2K | |
| 82985 | 107 | 94 | $2K | |
| 82232 | 40 | 37 | $1K | |
| 84295 | 664 | 513 | $1K | |
| 74220 | 43 | 37 | $1K | |
| 80197 | 267 | 193 | $1K | |
| 87517 | 271 | 208 | $1K | |
| A9558 | Xenon xe-133 gas, diagnostic, per 10 millicuries | 202 | 157 | $1K |
| 12013 | 28 | 24 | $1K | |
| 85014 | 1,261 | 909 | $1K | |
| 83921 | 174 | 77 | $1K | |
| 84132 | 816 | 551 | $1K | |
| 36561 | 26 | 12 | $1K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 108 | 68 | $1K |
| A0425 | Ground mileage, per statute mile | 85 | 62 | $1K |
| J9310 | Injection, rituximab, 100 mg | 17 | 12 | $1K |
| 70360 | 307 | 272 | $1K | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 1,687 | 1,216 | $1K |
| 51798 | 245 | 202 | $1K | |
| 92611 | 60 | 55 | $1K | |
| 74230 | 101 | 83 | $1K | |
| 83520 | 80 | 54 | $1K | |
| 83010 | 442 | 319 | $1K | |
| 72050 | 90 | 70 | $965.19 | |
| 80177 | 159 | 122 | $899.88 | |
| 86039 | 392 | 247 | $842.56 | |
| 82024 | 14 | 12 | $830.89 | |
| 88184 | 190 | 127 | $810.29 | |
| 87640 | 51 | 40 | $808.83 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 121 | 94 | $778.04 |
| 89050 | 149 | 110 | $777.09 | |
| 86705 | 61 | 50 | $730.71 | |
| 86256 | 15 | 14 | $729.18 | |
| 82172 | 259 | 190 | $597.18 | |
| 86304 | 13 | 12 | $568.03 | |
| 82677 | 49 | 37 | $566.16 | |
| 82040 | 128 | 101 | $537.46 | |
| P9040 | Red blood cells, leukocytes reduced, irradiated, each unit | 42 | 29 | $520.40 |
| 82374 | 160 | 123 | $446.79 | |
| 82435 | 161 | 124 | $438.59 | |
| 86593 | 76 | 51 | $418.92 | |
| 87147 | 325 | 241 | $414.82 | |
| 86336 | 49 | 37 | $403.92 | |
| C1758 | Catheter, ureteral | 45 | 39 | $355.59 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 58 | 38 | $349.16 |
| 82652 | 52 | 43 | $341.27 | |
| 80178 | 57 | 40 | $316.00 | |
| 36410 | 248 | 201 | $305.31 | |
| 81025 | 86 | 51 | $279.39 | |
| 96377 | 51 | 25 | $266.13 | |
| 84155 | 85 | 70 | $261.17 | |
| 82951 | 54 | 46 | $258.57 | |
| 90662 | 618 | 544 | $254.94 | |
| 84300 | 56 | 52 | $250.03 | |
| OP270 | 35 | 30 | $245.12 | |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 25 | 14 | $245.09 |
| G0009 | Administration of pneumococcal vaccine | 494 | 412 | $233.84 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 54 | 36 | $232.60 |
| 82310 | 104 | 74 | $220.82 | |
| 86308 | 42 | 38 | $211.72 | |
| 93017 | 217 | 149 | $205.53 | |
| 77012 | 49 | 39 | $202.42 | |
| 80047 | 77 | 36 | $195.31 | |
| 87116 | 57 | 40 | $167.17 | |
| 82962 | 578 | 457 | $162.59 | |
| 86696 | 13 | 12 | $153.46 | |
| 72220 | 18 | 12 | $152.27 | |
| 73660 | 59 | 52 | $151.25 | |
| 73501 | 22 | 12 | $149.88 | |
| 73521 | 73 | 63 | $149.28 | |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 54 | 42 | $147.05 |
| 88172 | 58 | 41 | $141.97 | |
| 73221 | 20 | 16 | $137.37 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 1,353 | 988 | $127.01 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 1,426 | 1,033 | $126.99 |
| 88311 | 91 | 69 | $116.65 | |
| 86695 | 13 | 12 | $104.63 | |
| J7510 | Prednisolone oral, per 5 mg | 131 | 115 | $104.18 |
| 88300 | 97 | 51 | $100.50 | |
| 86147 | 14 | 13 | $91.16 | |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 569 | 418 | $89.39 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 571 | 419 | $89.37 |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | 37 | 25 | $83.99 |
| 81002 | 214 | 166 | $83.28 | |
| 82164 | 51 | 31 | $81.03 | |
| 86762 | 57 | 45 | $66.07 | |
| 87176 | 21 | 16 | $57.51 | |
| 87493 | 51 | 41 | $47.18 | |
| 93923 | 17 | 12 | $45.64 | |
| 86146 | 14 | 13 | $45.54 | |
| 87206 | 54 | 38 | $41.61 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 18 | 12 | $32.31 |
| 77091 | 29 | 16 | $29.47 | |
| 84478 | 46 | 24 | $18.75 | |
| 86870 | 32 | 26 | $15.00 | |
| 86709 | 19 | 16 | $13.90 | |
| 90688 | 168 | 130 | $6.74 | |
| 91300 | 366 | 321 | $0.74 | |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 23 | 13 | $0.57 |
| 91301 | 53 | 44 | $0.10 | |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 560 | 399 | $0.09 |
| G8996 | Swallowing functional limitation, current status at therapy episode outset and at reporting intervals | 367 | 274 | $0.05 |
| G8997 | Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 370 | 276 | $0.05 |
| G8989 | Self care functional limitation, discharge status, at discharge from therapy or to end reporting | 155 | 127 | $0.02 |
| G8998 | Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting | 232 | 175 | $0.02 |
| Q0247 | Injection, sotrovimab, 500 mg | 21 | 20 | $0.01 |
| 90682 | 18 | 14 | $0.00 | |
| 72114 | 51 | 49 | $0.00 | |
| 84481 | 18 | 15 | $0.00 | |
| C1788 | Port, indwelling (implantable) | 26 | 12 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 94 | 77 | $0.00 |
| 10022 | 17 | 12 | $0.00 | |
| 94727 | 12 | 12 | $0.00 | |
| C1729 | Catheter, drainage | 21 | 13 | $0.00 |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 13 | 12 | $0.00 |
| 76942 | 16 | 12 | $0.00 | |
| 95811 | 16 | 14 | $0.00 | |
| 86225 | 70 | 61 | $0.00 | |
| 64400 | 17 | 12 | $0.00 | |
| 86255 | 17 | 12 | $0.00 | |
| 87449 | 13 | 12 | $0.00 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 15 | 12 | $0.00 |
| 82945 | 17 | 12 | $0.00 | |
| 88331 | 20 | 12 | $0.00 | |
| 29130 | 12 | 12 | $0.00 | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 95 | 12 | $0.00 |